-->

Revelation Biosciences Stock Book Value Per Share

REVBW Stock  USD 0.02  0.0003  1.71%   
Fundamental analysis of Revelation Biosciences allows traders to better anticipate movements in Revelation Biosciences' stock price by examining its financial health and performance throughout various phases of its business cycle.
Last ReportedProjected for Next Year
Book Value Per Share 27.45  26.08 
Tangible Book Value Per Share 27.45  26.08 
Book Value Per Share is likely to drop to 26.08 in 2025. Tangible Book Value Per Share is likely to drop to 26.08 in 2025.
  
Build AI portfolio with Revelation Stock
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Revelation Biosciences Company Book Value Per Share Analysis

Revelation Biosciences' Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Book Value per Share

 = 

Common Equity

Average Shares

More About Book Value Per Share | All Equity Analysis

Current Revelation Biosciences Book Value Per Share

    
  8.97 X  
Most of Revelation Biosciences' fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Revelation Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Revelation Book Value Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for Revelation Biosciences is extremely important. It helps to project a fair market value of Revelation Stock properly, considering its historical fundamentals such as Book Value Per Share. Since Revelation Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Revelation Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Revelation Biosciences' interrelated accounts and indicators.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Competition

Revelation Common Stock Shares Outstanding

Common Stock Shares Outstanding

180,086

At this time, Revelation Biosciences' Common Stock Shares Outstanding is fairly stable compared to the past year.
In accordance with the recently published financial statements, the book value per share of Revelation Biosciences is about 8.967 times. This is 627.47% lower than that of the Biotechnology sector and 103.61% lower than that of the Health Care industry. The book value per share for all United States stocks is 99.54% higher than that of the company.

Revelation Book Value Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Revelation Biosciences' direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Revelation Biosciences could also be used in its relative valuation, which is a method of valuing Revelation Biosciences by comparing valuation metrics of similar companies.
Revelation Biosciences is currently under evaluation in book value per share category among its peers.

Revelation Biosciences Current Valuation Drivers

We derive many important indicators used in calculating different scores of Revelation Biosciences from analyzing Revelation Biosciences' financial statements. These drivers represent accounts that assess Revelation Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Revelation Biosciences' important valuation drivers and their relationship over time.
202020212022202320242025 (projected)
Market Cap91.4M100.7M10.8M10.3M3.8M3.6M
Enterprise Value91.4M99.4M5.5M(1.7M)(2.7M)(2.6M)

Revelation Fundamentals

About Revelation Biosciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Revelation Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revelation Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revelation Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revelation Stock Analysis

When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.